Literature DB >> 2213040

Botulinum toxin treatment in spasmodic torticollis.

J D Blackie1, A J Lees.   

Abstract

Botulinum toxin A was administered to 19 patients in a double-blind placebo controlled trial. Toxin was more effective than placebo for improving both head position and pain which was measured by an objective rating scale and videofilm assessments. Following the controlled trial, treatment with botulinum toxin was continued in an open fashion. A total of 60 patients with torticollis received toxin in a total of 117 treatment periods. The mean follow up period was 8.4 months. In 39 patients with pain there was benefit in 77% of treatment periods. Some improvement in neck posture occurred in 83% of the treatment periods with a mean duration of 12 weeks. Side effects were frequent with dysphagia being the most common (28% of treatment periods). Botulinum toxin is an effective treatment for toticollis but treatment should be initiated with doses at the lower end of the range used in this study (400-600 mouse units).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213040      PMCID: PMC488163          DOI: 10.1136/jnnp.53.8.640

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  [Spasmodic torticollis and electromyography].

Authors:  A Tournay; J Paillard
Journal:  Rev Neurol (Paris)       Date:  1955       Impact factor: 2.607

2.  Botulinum toxin treatment of blepharospasm.

Authors:  J S Elston
Journal:  Adv Neurol       Date:  1988

3.  Botulinum toxin in spasmodic torticollis.

Authors:  J K Tsui; A Eisen; D B Calne
Journal:  Adv Neurol       Date:  1988

4.  Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia.

Authors:  C L Ludlow; R F Naunton; S E Sedory; G M Schulz; M Hallett
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

5.  Reversible esophageal motor dysfunction in botulism.

Authors:  W A Nix; V F Eckardt; G Krämer
Journal:  Muscle Nerve       Date:  1985 Nov-Dec       Impact factor: 3.217

6.  A pilot study on the use of botulinum toxin in spasmodic torticollis.

Authors:  J K Tsui; A Eisen; E Mak; J Carruthers; A Scott; D B Calne
Journal:  Can J Neurol Sci       Date:  1985-11       Impact factor: 2.104

7.  Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study.

Authors:  J Jankovic; J Orman
Journal:  Neurology       Date:  1987-04       Impact factor: 9.910

8.  Effect of treatment with botulinum toxin on neurogenic blepharospasm.

Authors:  J S Elston; R W Russell
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

9.  Distant effects of local injection of botulinum toxin.

Authors:  D J Lange; M F Brin; C L Warner; S Fahn; R E Lovelace
Journal:  Muscle Nerve       Date:  1987 Jul-Aug       Impact factor: 3.217

10.  Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves.

Authors:  J D Black; J O Dolly
Journal:  J Cell Biol       Date:  1986-08       Impact factor: 10.539

View more
  27 in total

1.  Botulinum toxin.

Authors:  A J Lees
Journal:  BMJ       Date:  1992-11-14

2.  Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients.

Authors:  W Poewe; L Schelosky; B Kleedorfer; F Heinen; M Wagner; G Deuschl
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

Review 3.  Botulinum toxin for cerebral palsy; where are we now?

Authors:  R E Morton; J Hankinson; J Nicholson
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

4.  A double blind trial of botulinum toxin "A" in torticollis, with one year follow up.

Authors:  A P Moore; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

5.  What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group.

Authors:  W Poewe; G Deuschl; A Nebe; E Feifel; J Wissel; R Benecke; K R Kessler; A O Ceballos-Baumann; A Ohly; W Oertel; G Künig
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

6.  Oropharyngeal swallowing in craniocervical dystonia.

Authors:  C Ertekin; I Aydogdu; Y Seçil; N Kiylioglu; S Tarlaci; T Ozdemirkiran
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

7.  Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin.

Authors:  A J Lees; N Turjanski; J Rivest; R Whurr; M Lorch; G Brookes
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

8.  Botulinum Toxin Deaths: What is the Fact?

Authors: 
Journal:  J Cutan Aesthet Surg       Date:  2008-07

9.  Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.

Authors:  G L Sheean; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

10.  Botulinum toxin type A in the treatment of patients with cervical dystonia.

Authors:  Allison Brashear
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.